An ancient signaling pathway and 20 years of research offer hope for rare cancer

byPeter MacCallum Cancer CentreCredit:EMBO Reports(2024). DOI: 10.1038/s44319-024-00217-3Researchers at Peter Mac are using their knowledge of an ancient signaling pathway to find ne

Updated on: September 07,2024

An ancient signaling pathway and 20 years of research offer hope for rare cancer

byPeter MacCallum Cancer CentreCredit:EMBO Reports(2024). DOI: 10.1038/s44319-024-00217-3Researchers at Peter Mac are using their knowledge of an ancient signaling pathway to find ne

Updated on:September 07,2024

Researchers test novel gene therapy for glioblastoma

by University Hospitals Cleveland Medical CenterGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0A novel gene therapy clinical trial at University Hospitals Seidman Cancer Center and

Updated on: June 24,2024

Researchers test novel gene therapy for glioblastoma

by University Hospitals Cleveland Medical CenterGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0A novel gene therapy clinical trial at University Hospitals Seidman Cancer Center and

Updated on:June 24,2024

Researchers develop approach that could help supercharge T-cell therapies against solid tumors

by National Institutes of HealthCredit: CC0 Public DomainResearchers at the National Institutes of Health have developed a way to potentially increase the effectiveness of T cell–based immunother

Updated on: June 08,2024

Researchers develop approach that could help supercharge T-cell therapies against solid tumors

by National Institutes of HealthCredit: CC0 Public DomainResearchers at the National Institutes of Health have developed a way to potentially increase the effectiveness of T cell–based immunother

Updated on:June 08,2024

Multigene testing replacing BRCA tests for breast cancer risk, researcher says

by Stanford University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014

Updated on: June 24,2024

Multigene testing replacing BRCA tests for breast cancer risk, researcher says

by Stanford University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014

Updated on:June 24,2024

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

by Stanford University Medical CenterCredit: CC0 Public DomainInduced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become

Updated on: June 06,2024

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

by Stanford University Medical CenterCredit: CC0 Public DomainInduced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become

Updated on:June 06,2024

Immunotherapy research offers new hope for children with primary liver carcinomas

by Jessica Cerretani,Children's Hospital BostonSwimmers plots for each individual patient course. Credit:eBioMedicine(2024). DOI: 10.1016/j.ebiom.2024.105147Pediatric hepatocellu

Updated on: September 07,2024

Immunotherapy research offers new hope for children with primary liver carcinomas

by Jessica Cerretani,Children's Hospital BostonSwimmers plots for each individual patient course. Credit:eBioMedicine(2024). DOI: 10.1016/j.ebiom.2024.105147Pediatric hepatocellu

Updated on:September 07,2024

Researchers discover 40 genes involved in early development of myeloma

by Sarah Wells, The Institute of Cancer ResearchMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Researchers have revealed 40 ge

Updated on: June 24,2024

Researchers discover 40 genes involved in early development of myeloma

by Sarah Wells, The Institute of Cancer ResearchMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0Researchers have revealed 40 ge

Updated on:June 24,2024

Researchers to test novel drug combination against toughest breast cancers

by University of California - San DiegoThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: National Ins

Updated on: June 15,2024

Researchers to test novel drug combination against toughest breast cancers

by University of California - San DiegoThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: National Ins

Updated on:June 15,2024

Research points to an immunotherapy to overcome resistant leukemia

by University of ZurichTP53 deficiency in AML leads to resistance against CAR T-cell-mediated killing that can be overcome by targeting the mevalonate and Wnt pathways. Credit:EMBO Molecula

Updated on: March 30,2024

Research points to an immunotherapy to overcome resistant leukemia

by University of ZurichTP53 deficiency in AML leads to resistance against CAR T-cell-mediated killing that can be overcome by targeting the mevalonate and Wnt pathways. Credit:EMBO Molecula

Updated on:March 30,2024

Five-year interval is safe for prostate cancer screening, research shows

by European Association of UrologyCredit: CC0 Public DomainA simple blood test every five years is sufficient to screen low risk men for prostate cancer, new research has shown.The PSA blood test

Updated on: April 06,2024

Five-year interval is safe for prostate cancer screening, research shows

by European Association of UrologyCredit: CC0 Public DomainA simple blood test every five years is sufficient to screen low risk men for prostate cancer, new research has shown.The PSA blood test

Updated on:April 06,2024

Researchers find a 'critical need' for whole genome sequencing of young cancer patients

by St. Jude Children's Research HospitalSt. Jude investigators (from left) Michael Rusch, Sheila Shurtleff, Ph.D., Jinghui Zhang, Ph.D., and Scott Newman, Ph.D. Credit: St. Jude Children'

Updated on: June 22,2024

Researchers find a 'critical need' for whole genome sequencing of young cancer patients

by St. Jude Children's Research HospitalSt. Jude investigators (from left) Michael Rusch, Sheila Shurtleff, Ph.D., Jinghui Zhang, Ph.D., and Scott Newman, Ph.D. Credit: St. Jude Children'

Updated on:June 22,2024

Researchers report on ctDNA-based detection of residual disease prognostic for resected CRC

by Elana GotkineFor patients with radically resected, stage II to IV colorectal cancer (CRC), circulating tumor (ct)DNA-based detection of molecular residual disease (MRD) in response to adjuvant chem

Updated on: March 05,2024

Researchers report on ctDNA-based detection of residual disease prognostic for resected CRC

by Elana GotkineFor patients with radically resected, stage II to IV colorectal cancer (CRC), circulating tumor (ct)DNA-based detection of molecular residual disease (MRD) in response to adjuvant chem

Updated on:March 05,2024